Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | TOP1 | P11387 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mannitol SCHEMBL22575783 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL28092438 | 0.95 | LMNA (0.65) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL27743384 | 0.92 | LMNA (0.61) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| E968 SCHEMBL14793512 | 0.89 | LMNA (0.40) | LMNAL3MBTL1TDP1KDM4E | |
| Xylitol SCHEMBL9070177 | 0.89 | LMNA (0.56) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL20640359 | 0.87 | LMNA (0.55) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Sorbitol SCHEMBL1220679 | 0.83 | LMNA (0.50) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Sorbitol SCHEMBL7769394 | 0.83 | LMNA (0.50) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Sorbitol SCHEMBL11254388 | 0.83 | LMNA (0.85) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL21081888 | 0.83 | LMNA (0.85) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3989916-A1 | OIL-IN- WATER EMULSION GEL COMPOSITION | L V M H RECHERCHE (FR) | 2022-05-04 | — | — | EP | disclosed |
| WO-2021048577-A1 | OIL-IN- WATER EMULSION GEL COMPOSITION | L V M H RECHERCHE (FR) | 2021-03-18 | — | — | WO | disclosed |
| US-20200199689-A1 | Method for Predicting Effectiveness of Angiogenesis Inhibitor | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-1862301-B1 | Image recording material, planographic printing plate precursor, and planographic printing method using the same | FUJIFILM CORP (JP) | 2011-09-28 | — | — | EP | disclosed |
| US-20070298351-A1 | IMAGE RECORDING MATERIAL, PLANOGRAPHIC PRINTING PLATE PRECURSOR, AND PLANOGRAPHIC PRINTING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2007-12-27 | — | — | US | disclosed |
| EP-1862301-A1 | Image recording material, planographic printing plate precursor, and planographic printing method using the same | FUJIFILM Corporation (JP) | 2007-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199689-A1 | Method for Predicting Effectiveness of Angiogenesis Inhibitor | VEGFA, BRAF, FLT4 | LMNA 4287/4885L3MBTL1 1840/4885TDP1 2490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.